Dissecting PAF, an Accelerator of Colorectal Cancer

剖析 PAF——结直肠癌的加速剂

基本信息

  • 批准号:
    9437724
  • 负责人:
  • 金额:
    $ 36.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-03-09 至 2020-02-29
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Fine control of Wnt signaling is essential for various cellular and developmental processes. However, deregulated Wnt signaling leads to colorectal cancer (CRC). Thus, elucidating the regulatory mechanisms of Wnt signaling to allow for its targeted manipulation is critical in CRC treatment. Our long-term goal is (i) to unravel distinct molecular mechanisms that promote intestinal tumorigenesis and (ii) to develop therapeutic methods to counter CRC cell proliferation and metastasis. Previous Studies - In addition to our consistent interest in Wnt signaling in cancer and development, we recently revealed that PCNA-associated factor (PAF) hyperactivates Wnt signaling and promotes CRC cell proliferation, strongly implies that PAF promotes intestinal tumorigenesis. Despite biologic functions of PAF in controlling DNA repair and Wnt signaling, pathologic roles of PAF in cancer are undetermined. Significance - With efforts by biotechnology groups have produced only limited success to date, there is a critical need to develop novel approaches to block the Wnt pathway. One complication is that Wnt signaling is indispensable to tissue homeostasis and regeneration. Thus, the targeting of Wnt signaling regulators whose expression is specifically restricted to cancer provides an opportunity to minimize normal tissue damage. Importantly, PAF expression is significantly elevated in CRC, but not in normal tissues. Additionally, PAF knockout (KO) mice are viable. These evidences indicate potential therapeutic advantages of specifically inhibiting Wnt signaling through manipulating PAF, a Wnt signaling regulator we identified. Thus, our proposed study is necessary to determine whether PAF is a therapeutic target for CRC. Based on our previous studies and preliminary results, we hypothesize that PAF accelerates intestinal tumorigenesis via Wnt signaling and epigenetic gene regulation. To test our hypothesis, we will accomplish the following specific aims: Aim 1 to determine in vivo tumorigenic role of PAF, using our genetically engineered mouse models; Aim 2 to dissect PAF-mediated silencing mechanism of Wnt antagonist in CRC; Aim 3 to determine the mechanism of PAF upregulation in CRC.
 描述(由申请人提供):Wnt信号传导的精细控制对于各种细胞和发育过程至关重要。然而,失调的Wnt信号传导导致结直肠癌(CRC)。因此,阐明Wnt信号传导的调节机制以允许其靶向操纵在CRC治疗中至关重要。我们的长期目标是(i)解开促进肠道肿瘤发生的不同分子机制,(ii)开发治疗方法来对抗CRC细胞增殖和转移。以前的研究-除了我们对癌症和发展中的Wnt信号传导的一贯兴趣外,我们最近发现PCNA相关因子(PAF)过度激活Wnt信号传导并促进CRC细胞增殖,强烈暗示PAF促进肠道肿瘤发生。尽管PAF在控制DNA修复和Wnt信号传导中具有生物学功能,但PAF在癌症中的病理作用尚未确定。意义-生物技术小组的努力迄今为止只取得了有限的成功,迫切需要开发新的方法来阻断Wnt途径。一个复杂的问题是,Wnt信号是组织稳态和再生不可或缺的。因此,Wnt信号传导调节剂(其表达被特异性地限制于癌症)的靶向提供了使正常组织损伤最小化的机会。重要的是,PAF表达在CRC中显著升高,但在正常组织中不显著。此外,PAF敲除(KO)小鼠是存活的。这些证据表明,通过操纵PAF特异性抑制Wnt信号传导具有潜在的治疗优势,PAF是我们鉴定的Wnt信号传导调节剂。因此,我们提出的研究是必要的,以确定是否PAF是CRC的治疗靶点。基于我们以前的研究和初步结果,我们推测PAF通过Wnt信号和表观遗传基因调控加速肠道肿瘤的发生。为了验证我们的假设,我们将完成以下具体目标:目的1,确定PAF在体内致瘤作用,使用我们的基因工程小鼠模型;目的2,剖析PAF介导的Wnt拮抗剂在CRC中的沉默机制;目的3,确定PAF在CRC中上调的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jae-Il Park其他文献

Jae-Il Park的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jae-Il Park', 18)}}的其他基金

Modeling Esophageal Squamous Cell Cancer Initiation
食管鳞状细胞癌发生建模
  • 批准号:
    10360687
  • 财政年份:
    2021
  • 资助金额:
    $ 36.6万
  • 项目类别:
PAF-Remodeled DREAM Complex in Cancer and Regeneration
PAF 重塑的 DREAM 复合物在癌症和再生中的作用
  • 批准号:
    10400151
  • 财政年份:
    2015
  • 资助金额:
    $ 36.6万
  • 项目类别:
PAF-Remodeled DREAM Complex in Cancer and Regeneration
PAF 重塑的 DREAM 复合物在癌症和再生中的作用
  • 批准号:
    10611929
  • 财政年份:
    2015
  • 资助金额:
    $ 36.6万
  • 项目类别:
Dissecting PAF, an Accelerator of Colorectal Cancer
剖析 PAF——结直肠癌的加速剂
  • 批准号:
    9222715
  • 财政年份:
    2015
  • 资助金额:
    $ 36.6万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 36.6万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.6万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 36.6万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.6万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 36.6万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.6万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 36.6万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 36.6万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 36.6万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.6万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了